Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07333547 · ClinicalTrials.gov registry record
Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform
A clinical trial, sponsored by Idoven 1903 S.L..
- Recruiting
- Registry status
- 200,000
- Enrollment target
NCT07333547 is a clinical trial that is actively recruiting participants, run by Idoven 1903 S.L.. The registered enrollment target is 200,000 participants.
The verdict
NCT07333547 is actively recruiting participants, sponsored by Idoven 1903 S.L..
- RECRUITING
- Registry status
- 200,000 participants
- Enrollment target
Study Summary
The WILLEM Registry is a large-scale, single-group, observational, registry study to collect continuous clinical evidence of Willem in real-world settings. Cardiovascular diseases are a major problem for public health and healthcare systems. Electrocardiograms (ECGs) are simple tests which increase diagnostic performance and early detection of cardiovascular diseases. However, its interpretation is complex, time consuming for cardiology experts, and entails high costs for healthcare systems. Willem allows AI-based automatic interpretation and its performance has been examined in previous clinical trials, but additional clinical evidence is needed for its integration in real-world clinical settings. This study will collect clinical evidence of Willem performance to detect cardiac abnormalities in ECGs from high-risk cardiac patients admitted to cardiovascular units.
Interventions
- DEVICE Willem AI ECG assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2026-02-03 |
| Est. Completion | 2036-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07333547
The ClinicalTrials.gov registry entry for NCT07333547 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Idoven 1903 S.L., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Willem AI ECG assessment is the first listed.
NCT07333547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07333547 about?
NCT07333547 is a clinical study titled "Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform". The WILLEM Registry is a large-scale, single-group, observational, registry study to collect continuous clinical evidence of Willem in real-world settings. Cardiovascular diseases are a major problem for public health and healthcare systems. Electrocardiograms (ECGs) are simple tests which increase ...
What is the current status of trial NCT07333547?
This trial is currently recruiting. The enrollment target is 200,000 participants. The study started on 2026-02-03. Estimated completion is 2036-01.
What interventions are being tested in trial NCT07333547?
The interventions under investigation include: Willem AI ECG assessment (DEVICE).
Who is sponsoring clinical trial NCT07333547?
This trial is sponsored by Idoven 1903 S.L., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.